Para citar este trabalho use um dos padrões abaixo:
Açaí (Euterpe oleracea Mart.) is a fruit native to the Brazilian Amazon region, and its processing generates significant volumes of seeds. Although these are underutilized, stand out as a source of phenolic compounds and have potential for application in the food industry. In this context, the growing demand for functional foods has driven the development of dairy beverages as matrices for incorporating bioactive extracts. However, foods containing açaí seeds in their composition remain largely unexplored. Thus, this study aimed to evaluate the bioactive potential of dairy beverages enriched with an infusion of roasted açaí berry powder, both before and after simulated in vitro digestion, with an emphasis on the phenolic profile and antioxidant and hypoglycemic activities. Four formulations were developed with increasing concentrations of the infusion, corresponding to 0% (F0), 3% (F3), 6% (F6), and 9% (F9), while keeping the other components of the dairy beverages constant. The formulations were subjected to the oral, gastric, and intestinal phases of in vitro digestion and subsequently evaluated before and after digestion for their phenolic compound profiles using high-performance liquid chromatography with a diode array detector (HPLC-DAD), employing analytical standards and external calibration curves. Antioxidant activities were determined using the DPPH and FRAP assays, and hypoglycemic potential was assessed by α-amylase inhibition. HPLC-DAD analysis revealed significant differences among the formulations, highlighting the influence of the concentration of the açaí berry infusion on the phenolic compound profile. Before digestion, F9 showed the highest levels of 3,4-dihydroxybenzoic acid, 4-hydroxybenzoic acid, catechin, syringic acid, gallic acid, and myricetin. After digestion, a significant reduction in several compounds was observed, with F6 showing higher levels of 3,4-dihydroxybenzoic acid, gallic acid, 4-hydroxybenzoic acid, and syringic acid, while F9 stood out for the persistence of naringin and ferulic acid. These results demonstrate that the concentration of the infusion modulated the phenolic profile of the beverages, and, following gastrointestinal digestion, changes occurred in the composition and bioaccessibility of these compounds. Regarding bioactivities, significant differences were observed among the formulations (Tukey, p < 0.05). In the DPPH assay, F6 (76%) and F9 (80%) exhibited the highest activities before in vitro digestion, with no significant difference between them. For FRAP, F9 showed the highest value before (61%) and after digestion (28%). Regarding hypoglycemic activity, F9 (82%) exhibited the highest inhibition levels before digestion, while after digestion, F9 (68%) remained superior to the other formulations. Overall, the results demonstrate the potential of roasted açaí berry powder infusion as a functional ingredient in dairy beverages, with formulation F9 standing out for exhibiting the most favorable combination of the evaluated characteristics. These results reinforce the feasibility of utilizing açaí seed, adding value to this byproduct and promoting its sustainable use in the production chain.
Acknowledgments: CAPES.
Com ~200 mil publicações revisadas por pesquisadores do mundo todo, o Galoá impulsiona cientistas na descoberta de pesquisas de ponta por meio de nossa plataforma indexada.
Confira nossos produtos e como podemos ajudá-lo a dar mais alcance para sua pesquisa:
Esse proceedings é identificado por um DOI , para usar em citações ou referências bibliográficas. Atenção: este não é um DOI para o jornal e, como tal, não pode ser usado em Lattes para identificar um trabalho específico.
Verifique o link "Como citar" na página do trabalho, para ver como citar corretamente o artigo